Just Biotherapeutics
Business Services · Washington, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
454 N 34th St, Seattle, Washington, 9810...Phone Number
(206) 651-5094Website
www.justbiotherapeutics.comRevenue
$17.3 MillionIndustry
About Just Biotherapeutics
Just Biotherapeutics Org Chart
Is Just Biotherapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Just Biotherapeutics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Just Biotherapeutics has new funding data
Just Biotherapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Just Biotherapeutics
Product Launch: Get notified when Just Biotherapeutics launches new products
Check if Just Biotherapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Just Biotherapeutics is spiking on competitors!
Click to see if Just Biotherapeutics had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Just Biotherapeutics
Find more new buyers
Compare Similar Companies to Just Biotherapeutics
Compare insights from companies similar to Just Biotherapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Just Biotherapeutics
Company Profile Activity
Activity Insights
Just Biotherapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Just Biotherapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Just Biotherapeutics.
Just Biotherapeutics financials insights
Gather financial insights about Just Biotherapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$14M
Series B
$57M
Just Biotherapeutics Tech Stack
A closer look at the technologies used by Just Biotherapeutics
Most Recent Scoops
Just Biotherapeutics News & Media
G-CON Manufacturing and Just – Evotec Biologics Complete the Installation of Cleanroom PODs® for the First J.POD® Facility in North America
Just – Evotec Biologics’ Redmond, Washington site offers true meaning to “Facility of the Future” with flexible and podular manufacturing of clinical and commercial-stage biologics. (PRWeb March 16, 2021) Read the full story at https://www.prweb.com/releases/g_con_manufacturing_and_just_evotec_biologics_complete_the_installation_of_cleanroom_pods_for_the_first_j_pod_facility_in_north_america/prweb17797069.htmG-CON PODs® Selected as Supplier for Clinical and Commercial Manufacturing Facility in Redmond, Washington
G-CON to supply prefabricated modular cGMP manufacturing suites for Just – Evotec Biologics’ first J.POD® facility in North America (PRWeb February 27, 2020) Read the full story at https://www.prweb.com/releases/g_con_pods_selected_as_supplier_for_clinical_and_commercial_manufacturing_facility_in_redmond_washington/prweb16939053.htmEvotec completes Just.Bio acquisition
Evotec SE has completed its acquisition of Just Biotherapeutics (Just.Bio). Evotec says the deal will strengthen its multimodality approach to R&D.Evotec Completes Acquisition Of Just Biotherapeutics
ACQUISITION EXTENDS EVOTEC'S MULTIMODALITY OFFERING, WITH INTEGRATED SOLUTIONS FOR SMALL MOLECULES AND BIOLOGICS EXPANDS EVOTEC'S US FOOTPRINT IN SEATTLE AND MACHINE LEARNING CAPABILITIES DEAL VALUE OF $ 90 M INCLUDING POTENTIAL EARN-OUTS HAMBURG, GERMANY / ACCESSWIRE / July 3, 2019 / Evotec SE (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced that the strategic transaction to acquire Just Biotherapeutics ("Just.Bio"), signed on 20 May 2019, has been completed. The acqu
Top Business Services Companies
Frequently Asked Questions Regarding Just Biotherapeutics
Just is an integrated design company focused on the technology of biotherapeutics, from molecule to manufacturing plant. The company believes that technological innovation will accelerate biotherapeutic development and dramatically reduce the cost of these vital medicines.... Read More